The drugmaker's chief executive says the group is open to an upgrade as the United States contributes more than half of revenue.

FREE MEMBER LOGIN

LOGIN TO CONTINUE READING.

Create or use your free IMG login to read standard articles. Important and Premium analysis also requires an active ₹99 or ₹199 plan.

The public preview and the member article share the same canonical page. No personalised investment recommendation is provided.